Who has invested in eTheRNA immunotherapies?

PMV, LSP, Boehringer Ingelheim, Fund+, Omega Funds, Grand Decade are named among the investors backing eTheRNA immunotherapies.

eTheRNA immunotherapies Funding: $104M Raised, Series B

eTheRNA immunotherapies funding overview

eTheRNA immunotherapies is based in Niel, Belgium. eTheRNA immunotherapies has raised $104M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in August 2022. The round record for eTheRNA immunotherapies runs through 2022; nothing later has been disclosed. Investors on record include PMV, LSP, Boehringer Ingelheim, Fund+, Omega Funds, Grand Decade and 2 others. 8 distinct backers are named across the disclosed rounds.

eTheRNA immunotherapies at a glance

Total raised: $104M
Latest round: Series B
Latest round date: August 2022
Headquarters: Niel, Belgium
Notable investors: PMV, LSP, Boehringer Ingelheim, Fund+, Omega Funds, Grand Decade, BNP Paribas Fortis, Novalis LifeSciences

Frequently asked about eTheRNA immunotherapies funding

How much has eTheRNA immunotherapies raised?: eTheRNA immunotherapies has raised $104M in total disclosed funding across the rounds on record.
Who has invested in eTheRNA immunotherapies?: PMV, LSP, Boehringer Ingelheim, Fund+, Omega Funds, Grand Decade are named among the investors backing eTheRNA immunotherapies.
What was the latest eTheRNA immunotherapies funding round?: The most recent disclosed round is a Series B, announced in August 2022.
Where is eTheRNA immunotherapies based?: eTheRNA immunotherapies is based in Niel, Belgium.
When did eTheRNA immunotherapies last raise?: The last disclosed eTheRNA immunotherapies round closed in August 2022 at Series B.

Every eTheRNA immunotherapies figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Niel at a similar stage.

eTheRNA immunotherapies Funding: $104M Raised, Series B

eTheRNA immunotherapies funding overview

eTheRNA immunotherapies at a glance

Frequently asked about eTheRNA immunotherapies funding

Companies related to eTheRNA immunotherapies (39)

Browse related funding lists (7)